Acadia Pharmaceuticals | ACAD - Ebitda





Ebitda Cambiamento Data
Acadia Pharmaceuticals USD 20.31M 15.44M 2025-12
ALKERMES USD 80.26M 20.05M 2026-03
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Biogen USD 649.7M 76.5M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Cara Therapeutics USD -2.39M 3.16M 2025-03
Corcept Therapeutics USD 4.2M 6.5M 2025-12
Cytokinetics USD -169.32M 19.48M 2026-03
Eisai JPY -335M 30.43B 2026-03
Eli Lilly USD 12.14B 4.26B 2025-12
Incyte USD 367.97M 46.53M 2026-03
J&J USD 7.19B 2.32B 2025-12
Moderna USD -790M 582M 2025-12
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
Prothena USD -39.53M 12.25M 2025-09
PTC Therapeutics USD -70.99M 91.62M 2025-12
Sarepta Therapeutics USD -252.2M 84.16M 2025-12
Ultragenyx Pharmaceutical USD -99.43M 57.35M 2025-12
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12
Vertex Pharmaceuticals USD 1.19B 195.3M 2026-03